
Scots cancer tot to get treatment abroad as locals rally round to raise cash
The parents of a tot with cancer have been left 'amazed' after the community raised money for potentially life-saving treatment abroad. Three-year-old Tommy Quinn was diagnosed with Neuroblastoma last year after a lump was found in his stomach. The discovery was made after Tommy had not wet his nappy, was hardly eating or sleeping, and was throwing up his bottle. Tommy is set to finish his NHS treatment this year and depending on the results of the scans, the plan is for him to go to either America or Europe for further treatment . But, the expenses may be less pressure for Tommy's parents after a 'stranger' set up a fundraiser to cover the costs. Tommy's mum Nicole Quinn, 37, said: "It was surreal when we got the diagnosis . Everything was like a whirlwind. "When the doctor felt the lump in his stomach, they told us that it could have been constipation. "But then, we were told it was a tumour." Tommy is currently undergoing immunotherapy treatment for the rare cancer which primarily affects children under the age of five. It develops from early nerve cells called neuroblasts and often starts in the abdomen. Despite the treatment making Tommy feel unwell at times, Nicole says the Bishopbriggs tot is still a cheeky and charming chap. She added: "He's terrorising the nurses and drawing everyone in with his cheeky smile. "He loves entertaining people. He's always been that way, even before the diagnosis." T in the Town Hall will take place at Airdrie Town Hall on May 10. The event has been organised by joiner Darren Meechan who was told about Tommy's story through a friend and decided to take it one step further. Darren, 37, said: "When I checked out who Tommy was, I discovered that he was about the same age as my son and car mad. "That really brought Tommy's story home to me because I couldn't imagine being in his parents' shoes." Darren asked Stevie Douglas of The McCommitments to perform at the fundraiser , where Darren will also be performing with his band, Deck Side of the Moon. There will also be 'Scotland's largest tool tombola' event at the fundraiser . Stevie, who is the lead singer of The McCommitments, has also turned his decommissioned London taxi into a portable gig venue to help raise even more funds for Tommy. Stevie said: "My plan is to drive around Scotland and let musicians come in and play a live show in there. This should hopefully raise awareness for Tommy as well as funds." Stevie even took Tommy for a spin in the taxi not too long ago - which the youngster loved. Stevie said: "Tommy is some wee boy. I remember joking and telling him the ride was a fiver and he tried to push his toy firetruck which he brought with him through the coin tray for payment. "When I drove home I just burst out greeting because it hit me like a ton of bricks." Nicole said she was 'amazed' when she learned about the fundraiser . She said: "These men don't really know us personally but they took Tommy under their wing. "The event - and especially the taxi - are a brilliant idea. "Times are so difficult for people right now, but for these strangers to take this on it just amazing."

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Daily Mirror
26 minutes ago
- Daily Mirror
'I thought WFH caused my leg pain - but it was my pill that nearly killed me'
Amy Pitt was prescribed the combined pill to prevent her getting pregnant following her IVF birth but then things took a worrying turn for the worse when she was admitted to hospital A mum put her aching leg down to being inactive while working from home - until doctors revealed she had deadly blood clots 'caused by the pill'. Amy Pitt was prescribed the combined pill in September 2024 to prevent her getting pregnant following her IVF birth and to help her gain weight. Having had no previous issues, when the 37-year-old began experiencing pain in her left leg in May she thought it was from not being active enough as she often works from home. However, after the civil servant's groin 'bulged' three inches bigger than its usual size and she experienced stomach pain days later she called 111 and was admitted to hospital on May 18. 'Extensive' blood clots were found in the major veins in her left leg that caused a pulmonary embolism, a life-threatening condition where a blood clot blocks an artery in the lungs - which doctors put down to using the birth control. Due to fly to Greek island of Crete a week later, doctors warned this 'could've been fatal for her' due to the cabin pressure and the mum-of-two says she is 'grateful that she's still here'. Despite using the same pill safely as a teenager, she now urges other women to 'make sure they're aware of the risks' before starting the oral contraceptive. The combined hormonal contraception pill causes the potential risk of a blood clot in your leg or lung, which affects one in 1,000 people, according to the NHS. Amy, who lives in Solihull, West Midlands, said: "It's just a bit shocking. My pill could have killed me. "I work from home and I started feeling the usual aches and pains in my left leg. I thought 'maybe it's because I don't do enough because I often work from home'. I'm not active or walking around but I'm not unfit. It just got gradually worse and it got to the point where it was aching quite a lot. I thought I'd pulled a muscle or something. "I contacted 111 and they said 'book an appointment, we'll send you a link'. I couldn't use the link but I thought 'I'm just going to leave it. It's not going to be anything serious. I'm wasting their time and they're clearly so busy'. "It was only the next day I woke up and it was swollen and a bit discoloured. My left leg felt longer than the other one. When I was standing straight, one wasn't touching the floor. "It's basically the groin bit that was solid and bulging. When I stood up it was very hard to touch. I got a tape measure out and one leg was two or three inches difference in the top of my leg. The pain had also gotten worse in my tummy." After calling 111 they booked her a hospital appointment and she had blood tests before scans to test for a possible tumour. However, numerous tests and scans revealed the parent had an occlusive thrombus and extensive blood clots in the major veins in her leg, which spread to her lungs and was said to be caused by the pill. Amy said: "It's just crazy because I'm only young and I've got a blood clot caused by the pill. The doctor said 'your blood clots are so extensive. One of them is completely blocking the blood flow. If you'd flown to Crete without realising due to the altitude due to the oxygen levels on the plane, it could've been fatal for you'. "I have two children so I was just thinking 'could you imagine if I'd gone on that flight. I could've been stuck in another country'. It's scary. "They said it was the pill and that I had to stop it today so it went straight in the bin. I should've looked at it before taking it again but you rely on the doctors to tell you what's suitable and what's not. "I'm so grateful I got checked out when I did. I just knew that I couldn't afford not to get this checked because I've got two children." The civil servant admitted her leg may stay swollen for up to a year and is currently taking blood thinning medication to allow the blood clots to dissolve. She now wants to spread awareness to other women about the potentially 'life-threatening' risks. Amy said: "I'm just grateful that I'm still here. Even now there's still potential that more clots could go from the leg to the lungs. I'm constantly on edge. 'Do I need to call the doctor'. It's given me a bit of anxiety. "It's just waiting for these clots to dissolve and hope that my life will get back to normal. I'm on blood thinners now so any bump to the head you have to call 111 because it can cause internal bleeding. I have to carry an alert card in case I'm in an accident. Thankfully I've had no injuries so far. "I don't think I was aware this was one of the risks. That's what I've got to take accountability for. In the small print of all these medications it does tell you all the risks. I think I was a bit naive. "Just make sure you talk to your doctor about the risks and make sure you're aware of the risks yourself. Read the small print. The odds of you getting one are low but the odds are still there. It could be life-threatening."


Daily Mirror
2 hours ago
- Daily Mirror
UKHSA issues urgent health warning after walking outdoors
People have been urged to look out for ticks, small creatures that can carry a number of infections. Brits have been issued an urgent warning to take care when walking outdoors this summer due to a serious risk to health. The UK Health Security Agency (UKHSA) has shared guidance on how to stay safe from ticks. Ticks are tiny, spider-like creatures that live in undergrowth and latch on to animals including humans when they walk through long grass. They are becoming more prevalent in parts of the UK, mainly due to increasing numbers of deer. While feeding, they can transmit viruses and infections that cause disease, with the most common being Lyme disease. In a post made to X, the UKHSA said: 'Summer's a great time to get outside, but ticks love the outdoors too. 'If you're walking through grassy or wooded areas, take a look at our guidance to help you stay safe and be tick aware.' In an infographic, it explained what to do if you find a tick on your body. What to do if you've been bitten by a tick 'Remove ticks as soon as you find them,' it said. 'If you have a tick removal device, follow its instructions or use a pair of fine-tipped tweezers.' Next you need to grasp the tick 'as close to the skin as you can'. The UKHSA explained: 'Pull upwards firmly, making sure all of the tick is removed.' You then need to clean the bite area with soap and water, and keep an eye on it for a few weeks in case of 'any changes' The health authority warned: 'Look out for a spreading bullseye rash, which is a common symptom of Lyme disease three to 30 days after being bitten. 'If you become unwell, for example with a spreading circular rash, flu-like symptoms, nerve pain or a droop on one or both sides of the face within a few weeks of a tick bite, call your GP practice or NHS 111.' Other potential symptoms of Lyme disease include: A high temperature, or feeling hot and shivery Headache Muscle and joint pain Tiredness and loss of energy The NHS warns that some people who are diagnosed and treated for Lyme disease continue to have symptoms, like tiredness, aches and loss of energy, that can last for years. 'These symptoms are often compared to fibromyalgia and chronic fatigue syndrome,' it says. 'It's not clear why this happens to some people and not others. This means there's also no agreed treatment.' You should speak to a doctor if your symptoms come back, or do not improve, after treatment with antibiotics. To reduce the risk of being bitten by a tick in the first place, the NHS recommends you:


The Independent
3 hours ago
- The Independent
Thousands of NHS patients ‘to be denied breakthrough Alzheimer's drugs'
Breakthrough drugs that slow the progression of Alzheimer's disease will reportedly be refused for use on the NHS this week in a blow to thousands of patients. The two drugs, Lecanemab and donanemab, slow down the decline in Alzheimer's patients' ability to carry out daily activities. The drugs' success in halting the progression of Alzheimer's was heralded as a 'new era' by campaigners and researchers. However, the National Institute for Health and Care Excellence (Nice) is expected to refuse to recommend them on the NHS, according to The Sunday Times. The regulator has already issued two decisions, one in October last year and another in March, saying they would not recommend the drugs for use on the NHS. A final decision will be published on Thursday. Both drugs already have UK drug licences, making them available privately. It is estimated that around 70,000 adults in England would have been eligible for treatment if the drugs had been approved. The regulator will reportedly turn down both drugs on the grounds of cost-effectiveness, with one insider telling The Sunday Times: 'It is the end of the road for these drugs on the NHS'. Lecanemab removes build-ups of the protein beta-amyloid from the brain. Trials showed that lecanemab can slow the progression of Alzheimer's by 27 per cent over 18 months if given to someone early on in the course of their decline. Donanemab, marketed as Kisunla in the UK, teaches the body's immune cells to recognise and remove the amyloid protein, which builds up in the brains of people with Alzheimer's disease. The protein build-ups are thought to be toxic to brain cells, leading to the symptoms of Alzheimer's, the Alzheimer's society has said. Lecanemab can, however, cause swelling and bleeding in the brain. In trials for Donanemab, a third of recipients experienced abnormalities in their brain scans caused by brain swelling and bleeding, NICE said. The drugs reportedly cost around £20,000 to £25,000, with the NHS being offered a lower price. Privately, the treatment costs between £60,000-80,000 per year, according to Alzheimer's Research UK. In a previous review by NICE in October 2024, director of medicines evaluation Helen Knight said: 'Donanemab could slow down cognitive decline by 4-7 months, but this is just not enough benefit to justify the additional cost to the NHS. The cost-effectiveness estimate for donanemab is five to six times above what NICE normally considers an acceptable use of NHS resources'. While the regulator said the decision would be disappointing for some, 'there are other treatments being developed'. Hilary Evans-Newton, chief executive of Alzheimer's Research UK, said the decision to turn down the drugs would be 'deeply disappointing'. She added: 'These treatments are not perfect, and we recognise the challenges they pose around cost, delivery and safety. But scientific progress is incremental, and these drugs represent a vital foundation to build on.' The regulator NICE is due to publish the final draft guidance about the two drugs on Thursday. This leaves space for the decision to be challenged and sent to a review panel before the final guidance is published.